Is Reactive Thrombocytosis Benign?

Reactive Thrombocytosis, or elevated blood platelet counts, may predict underlying disease and mortality risk and has been linked with poorer prognosis in COVID-19 patients. Explore in OTR.


Is marijuana mortality just smoke and mirrors?

Tetrahydrocannabinol (THC) use has increased substantially in the last decade. Curious what the science says about health impacts and mortality implications, and how use and age patterns can guide underwriting decisions? Read more.

Diabetes Test

Hitting a sweet spot with HbA1c.

As diabetes reaches record levels, could the standard glycated hemoglobin A1c test to detect diabetes also serve as a blood biomarker for mortality? Rethink the purpose of this popular test.


High-tech high?

Some are calling it the new addiction of the 21st century. Learn more about the physical and psychological implications of smartphone addiction and how it could impact life and disability insurance applica­tions in OTR.

Stroke in Younger Ages

The unfamiliar face of stroke

The face of stroke is younger than ever before. Out of every six strokes occurs in young adults, with stroke hospitalization rates on the rise among patients aged 18-64. Explore the risk factors in OTR.